These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17996097)

  • 41. Linking Coach Interpersonal Style With Athlete Doping Intentions and Doping Use: A Prospective Study.
    Ntoumanis N; Barkoukis V; Gucciardi DF; Chan DKC
    J Sport Exerc Psychol; 2017 Jun; 39(3):188-198. PubMed ID: 28891379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can We Better Integrate the Role of Anti-Doping in Sports and Society? A Psychological Approach to Contemporary Value-Based Prevention.
    Petróczi A; Norman P; Brueckner S
    Med Sport Sci; 2017; 62():160-176. PubMed ID: 28571017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doping in Sport-Attitudes of Physical Trainers Students Regarding the Use of Prohibited Substances Increasing Performance.
    Zmuda Palka M; Bigosińska M; Siwek M; Angelova-Igova B; Mucha DK
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An examination of the Sport Drug Control Model with elite Australian athletes.
    Gucciardi DF; Jalleh G; Donovan RJ
    J Sci Med Sport; 2011 Nov; 14(6):469-76. PubMed ID: 21514883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of West-Austrian junior athletes' knowledge regarding doping in sports.
    Fürhapter C; Blank C; Leichtfried V; Mair-Raggautz M; Müller D; Schobersberger W
    Wien Klin Wochenschr; 2013 Jan; 125(1-2):41-9. PubMed ID: 23292645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doping and supplementation: the attitudes of talented young athletes.
    Bloodworth AJ; Petróczi A; Bailey R; Pearce G; McNamee MJ
    Scand J Med Sci Sports; 2012 Apr; 22(2):293-301. PubMed ID: 20973831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Doping in sports: knowledge and attitudes among parents of Austrian junior athletes.
    Blank C; Leichtfried V; Schaiter R; Fürhapter C; Müller D; Schobersberger W
    Scand J Med Sci Sports; 2015 Feb; 25(1):116-24. PubMed ID: 24372621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards an empirical model of performance enhancing supplement use: a pilot study among high performance UK athletes.
    Mazanov J; Petróczi A; Bingham J; Holloway A
    J Sci Med Sport; 2008 Apr; 11(2):185-90. PubMed ID: 17350333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychological mechanisms underlying doping attitudes in sport: motivation and moral disengagement.
    Hodge K; Hargreaves EA; Gerrard D; Lonsdale C
    J Sport Exerc Psychol; 2013 Aug; 35(4):419-32. PubMed ID: 23966451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Capturing doping attitudes by self-report declarations and implicit assessment: a methodology study.
    Petróczi A; Aidman EV; Nepusz T
    Subst Abuse Treat Prev Policy; 2008 Apr; 3():9. PubMed ID: 18426575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ["Enjoy the Sport - Schools against doping and drug dependence": a health education intervention in secondary schools].
    Masala D; D'Egidio V; Iona T; La Torre G
    Ig Sanita Pubbl; 2019; 75(4):271-282. PubMed ID: 31887733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The development and validation of the Adolescent Sport Drug Inventory (ASDI) among athletes from four continents.
    Nicholls AR; Levy AR; Meir R; Sanctuary C; Jones L; Baghurst T; Thompson MA; Perry JL
    Psychol Assess; 2019 Nov; 31(11):1279-1293. PubMed ID: 31318254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attitudes of coaches towards doping.
    Laure P; Thouvenin F; Lecerf T
    J Sports Med Phys Fitness; 2001 Mar; 41(1):132-6. PubMed ID: 11317161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whistleblowing against doping in sport: A cross-national study on the effects of motivation and sportspersonship orientations on whistleblowing intentions.
    Barkoukis V; Bondarev D; Lazuras L; Shakverdieva S; Ourda D; Bochaver K; Robson A
    J Sports Sci; 2021 May; 39(10):1164-1173. PubMed ID: 33337975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incongruence in doping related attitudes, beliefs and opinions in the context of discordant behavioural data: in which measure do we trust?
    Petróczi A; Uvacsek M; Nepusz T; Deshmukh N; Shah I; Aidman EV; Barker J; Tóth M; Naughton DP
    PLoS One; 2011 Apr; 6(4):e18804. PubMed ID: 21541317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.